儿童和年轻成人非酒精性脂肪性肝病的心血管疾病风险
瑞典全国性队列纳入699例≤25岁经组织学确诊的非酒精性脂肪性肝病(NAFLD)患者,匹配3353例无NAFLD或心血管疾病的对照。中位随访16.6年间,NAFLD患者主要不良心血管事件(MACE)发生率显著高于对照(aHR=2.33,95%CI=1.43–3.78),非酒精性脂肪性肝炎(NASH)者风险更高(aHR=5.27,95%CI=1.96–14.19)。
要点
- ≤25岁经活检确诊NAFLD者MACE风险显著高于匹配对照(aHR=2.33)。
- NASH患者MACE风险进一步升高(aHR=5.27)。
- NAFLD患者心律失常发生率亦显著升高(aHR=3.16)。
核心结论
- 与匹配的普通人群对照相比,经活检证实的儿童和年轻成人NAFLD患者MACE发生率显著更高,包括缺血性心脏病和充血性心力衰竭。
- 应优先开展研究以更好地描述儿童和年轻成人NAFLD患者的心血管风险特征。
研究设计与样本
- 瑞典全国性队列研究,纳入1966–2016年所有≤25岁经组织学确诊NAFLD且基线无心血管疾病的儿童和年轻成人(n=699)。
- NAFLD依据前瞻性记录的组织病理学定义,进一步分为单纯性脂肪变或NASH。
- NAFLD患者按≤1:5匹配无NAFLD或心血管疾病的普通人群对照(n=3353)。
- 采用Cox比例风险模型计算多变量校正HR(aHR)及95%CI,主要结局为MACE(缺血性心脏病、卒中、充血性心力衰竭或心血管死亡)。
- 次要分析探索新发心律失常的发生率。
主要发现
- 中位随访16.6年期间,NAFLD患者确诊MACE 33例、对照52例。
- NAFLD患者MACE发生率显著高于对照(3.1 vs 0.9/1000人年;差值=2.1/1000人年;aHR=2.33,95%CI=1.43–3.78)。
- 缺血性心脏病发生率差值=1.4/1000人年(aHR=3.07,95%CI=1.62–5.83),充血性心力衰竭差值=0.5/1000人年(aHR=3.89,95%CI=1.20–12.64)。
- NASH患者MACE发生率似进一步升高(aHR=5.27,95%CI=1.96–14.19)。
- 次要分析中NAFLD患者心律失常发生率显著更高(aHR=3.16,95%CI=1.49–6.68)。
关键数值与推荐
- NAFLD定义依据前瞻性记录的组织病理学,并分为单纯性脂肪变或NASH。
- MACE定义为缺血性心脏病、卒中、充血性心力衰竭或心血管死亡。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Longitudinal evidence is lacking regarding the long-term risk of major adverse cardiovascular events (MACE) in children and young adults with non-alcoholic fatty liver disease (NAFLD). DESIGN: This nationwide cohort study included all Swedish children and young adults ≤25 years old with histologically confirmed NAFLD and without underlying cardiovascular disease (CVD) at baseline (1966-2016; n=699). NAFLD was defined from prospectively recorded histopathology, and further categorised as simple steatosis or non-alcoholic steatohepatitis (NASH). NAFLD patients were matched to ≤5 population controls without NAFLD or CVD (n=3353). Using Cox proportional hazards modelling, we calculated multivariable-adjusted HRs (aHRs) and 95% CIs for incident MACE (ie, ischaemic heart disease, stroke, congestive heart failure or cardiovascular mortality). In secondary analyses, we also explored rates of incident cardiac arrhythmias. RESULTS: Over a median follow-up of 16.6 years, incident MACE was confirmed in 33 NAFLD patients and 52 controls. NAFLD patients had significantly higher rates of MACE than controls (3.1 vs 0.9/1000 person-years (PY); difference=2.1/1000 PY; aHR=2.33, 95% CI=1.43 to 3.78), including higher rates of ischaemic heart disease (difference=1.4/1000 PY; aHR=3.07, 95% CI 1.62 to 5.83) and congestive heart failure (difference=0.5/1000 PY; aHR=3.89, 95% CI=1.20 to 12.64). Rates of incident MACE outcomes appeared to be further augmented with NASH (aHR=5.27, 95% CI=1.96 to 14.19). In secondary analyses, NAFLD patients also had significantly higher rates of cardiac arrythmias (aHR=3.16, 95% CI=1.49 to 6.68). CONCLUSION: Compared with matched population controls, children and young adults with biopsy-proven NAFLD had significantly higher rates of incident MACE, including ischaemic heart disease and congestive heart failure. Research to better characterise cardiovascular risk in children and young adults with NAFLD should be prioritised.
引用
- Simon TG, Roelstraete B, Alkhouri N, et al. Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut. 2022. PMID: 36522149. doi:10.1136/gutjnl-2022-328105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。